Feature Channels: Infectious Diseases

Filters close
Released: 24-Oct-2023 1:35 PM EDT
From nanoplastics to airborne toxins: Pollution stories for media.
Newswise

Read the latest research news on air pollution, nanoplastics, waterborne illnesses and more in the Pollution channel on Newswise.

       
Released: 24-Oct-2023 12:05 PM EDT
How to slow the spread of deadly ‘superbugs’
University of Technology, Sydney

Harnessing new advances in genomic surveillance technology could help detect the rise of deadly ‘superbugs’

Released: 23-Oct-2023 5:05 PM EDT
How long should kids isolate after they’ve contracted COVID-19?
University of Southern California (USC)

School policies that require students with COVID-19 to stay out of the classroom for five days are more than sufficient.

Released: 20-Oct-2023 5:05 PM EDT
How cord-like aggregates of bacteria lead to tuberculosis infections
Cell Press

The ability of Mycobacterium tuberculosis (MTB), a serious respiratory infection, to form snake-like cords was first noted nearly 80 years ago.

Released: 20-Oct-2023 9:00 AM EDT
Johns Hopkins Study Supports Potential for Injectable ‘Chemical Vaccine’ For Malaria Using Atovaquone
Johns Hopkins Bloomberg School of Public Health

Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that resistance may not be the challenge scientists thought it was, particularly when using atovaquone as a malaria preventive.

16-Oct-2023 6:05 AM EDT
New ‘Subway Map’ of Lyme Disease Pathways Identifies Potential New Treatment Targets
Tufts University

Scientists at Tufts University School of Medicine have developed a genome-scale metabolic model or “subway map” of key metabolic activities of the bacterium that causes Lyme disease.

   
Newswise: Pandemic Prevention Consortium Announces New Leadership Team
Released: 19-Oct-2023 8:15 AM EDT
Pandemic Prevention Consortium Announces New Leadership Team
Tufts University

STOP Spillover, a project funded by the U.S. Agency for International Development (USAID) and led by Tufts University, has announced that the interim leadership team that was put in place in March 2023 will take on a permanent role for the next two years of the project.

Newswise: Therapeutic nanocarriers reduce lung inflammation in mice
Released: 19-Oct-2023 3:20 AM EDT
Therapeutic nanocarriers reduce lung inflammation in mice
National Institute of Biomedical Imaging and Bioengineering

There is no cure or FDA-approved therapy for acute respiratory distress syndrome, which has a high rate of mortality. Inflammation plays a major role in developing ARDS. Researchers at Ohio State University developed therapeutic nanocarriers using mice skin cells, which reduced inflammation in their lungs.

   
Newswise: Eyes may be the window to your soul, but the tongue mirrors your health
Released: 18-Oct-2023 7:05 PM EDT
Eyes may be the window to your soul, but the tongue mirrors your health
University of South Australia

A 2000-year-old practice by Chinese herbalists – examining the human tongue for signs of disease – is now being embraced by computer scientists using machine learning and artificial intelligence.

Released: 18-Oct-2023 5:05 PM EDT
Racing to defuse a ‘ticking’ public health time bomb
Yale University

The explosive rise in tick-borne diseases in many parts of the United States over the last five decades represents a major public health threat that demands innovative solutions, warns a group of Yale scientists.

12-Oct-2023 10:05 AM EDT
Study Finds Increased Risk of Guillain-Barré After COVID-19 Infection
American Academy of Neurology (AAN)

Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that people who received the mRNA vaccine from Pfizer-BioNTech were less likely to develop the disorder in the next six weeks than people who did not receive the mRNA vaccine.

16-Oct-2023 11:05 AM EDT
From One Nightmare to Another. Anthony Fauci’s New Concern
Georgetown University Medical Center

“What keeps you up at night?” It’s a question Anthony Fauci, MD, heard repeatedly over the course of his nearly four decades as director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Today, as the COVID-19 pandemic wanes, Fauci describes a new nemesis – lack of “corporate memory.”

Released: 18-Oct-2023 12:00 PM EDT
Cancer Experts Available to Discuss Continued Impact of Covid-19 on Cancer Care
American College of Surgeons (ACS)

Cancer researchers attending the American College of Surgeons Clinical Congress 2023 in Boston will share recent national data on cancer trends related to the pandemic.

Released: 17-Oct-2023 3:05 PM EDT
Pathogen that plagues food processing plants eradicated by blue light
American Society for Microbiology (ASM)

Blue light kills both dried cells and biofilms of the pathogen Listeria monocytogenes, a frequent contaminant of food processing facilities.

Released: 13-Oct-2023 12:40 PM EDT
UM School of Medicine Researchers Provide First Statewide Prevalence Data on Two New Emerging Pathogens in Healthcare Settings
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) researchers conducted a statewide survey of all patients on breathing machines in hospitals and long-term care facilities and found that a significant percentage of them harbored two pathogens known to be life-threatening in those with compromised immune systems.

Newswise: Which one is the optimal choice for swiftly increasing platelet levels in adult relapsed ITP: IVIg, glucocorticoids, or the combination of IVIg and glucocorticoids?
Released: 11-Oct-2023 5:05 PM EDT
Which one is the optimal choice for swiftly increasing platelet levels in adult relapsed ITP: IVIg, glucocorticoids, or the combination of IVIg and glucocorticoids?
Higher Education Press

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, conducted a multicenter comprehensive retrospective analysis to assess the effectiveness and safety of primary single-agent and combination therapies in treating adult patients with relapsed immune thrombocytopenia (ITP).

Newswise: Doubling Down on Known Protein Families
Released: 11-Oct-2023 11:00 AM EDT
Doubling Down on Known Protein Families
Lawrence Berkeley National Laboratory

Through a novel approach detailed in Nature, a massive computational analysis of microbiome datasets more than doubled the number of known protein families. This is the first time protein structures have been used to help characterize the vast array of microbial “dark matter.”

Newswise: An AI Tool That Can Help Forecast Viral Outbreaks
10-Oct-2023 1:05 PM EDT
An AI Tool That Can Help Forecast Viral Outbreaks
Harvard Medical School

EVEscape predicts future viral mutations, new variants using evolutionary, biological information

Newswise: Stopping the cycle of recurrent urinary tract infections in women
Released: 10-Oct-2023 10:05 AM EDT
Stopping the cycle of recurrent urinary tract infections in women
UT Southwestern Medical Center

A study by UT Southwestern Medical Center researchers is the first to demonstrate the long-term efficacy of electrofulguration, a minimally invasive outpatient procedure that treats chronic urinary tract infections (UTIs) among postmenopausal women.

Newswise: Evidence from the remains of 1918 flu pandemic victims contradicts long-held belief that healthy young adults were particularly vulnerable
5-Oct-2023 12:20 PM EDT
Evidence from the remains of 1918 flu pandemic victims contradicts long-held belief that healthy young adults were particularly vulnerable
McMaster University

New analysis of the remains of victims of the 1918 influenza pandemic, which killed an estimated 50 million people worldwide, contradicts the widespread belief the flu disproportionately impacted healthy young adults.

   
Released: 9-Oct-2023 4:05 AM EDT
Vulnerability to different COVID-19 mutations depends on previous infections and vaccination, study suggests
University of Cambridge

A person’s immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure – and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.

Newswise: Cedars-Sinai Infectious Disease Experts Featured at IDWeek Meeting
Released: 5-Oct-2023 8:05 PM EDT
Cedars-Sinai Infectious Disease Experts Featured at IDWeek Meeting
Cedars-Sinai

Cedars-Sinai infectious disease specialists and investigators will present research and discuss clinical advances throughout IDWeek, taking place in Boston from Oct. 11-15.

Newswise: $2.9M NIH grant awarded to Cizik School of Nursing researcher to fund real-time HIV prevention and substance use reduction strategies
Released: 5-Oct-2023 5:05 PM EDT
$2.9M NIH grant awarded to Cizik School of Nursing researcher to fund real-time HIV prevention and substance use reduction strategies
University of Texas Health Science Center at Houston

A four-year, $2.9 million grant to assess the implementation of real-time health intervention to decrease substance use and support HIV prevention strategies in young adults experiencing homelessness.

Released: 5-Oct-2023 9:30 AM EDT
Johns Hopkins Bloomberg School of Public Health Media Briefing on Preventing the Spread of Flu, COVID, and RSV This Fall
Johns Hopkins Bloomberg School of Public Health

The Johns Hopkins Bloomberg School of Public Health is hosting an expert briefing for the media from 2:00 p.m. to 2:30 p.m. EDT, Thursday, October 12, on how to take steps to stay healthy as COVID and RSV cases climb and flu season approaches.

Released: 4-Oct-2023 10:05 AM EDT
MSU expert: What to know about flu, RSV, new COVID-19 variant and new vaccine
Michigan State University

The new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.

Newswise: The Medical Minute: Uptick in COVID cases, new vaccine available
Released: 4-Oct-2023 9:10 AM EDT
The Medical Minute: Uptick in COVID cases, new vaccine available
Penn State Health

Cases of COVID-19 are up since this summer, and a new vaccine is available. A Penn State Health infectious disease expert offers the latest on the pandemic.

Released: 3-Oct-2023 10:05 AM EDT
Not all viruses are harmful
Virginia Tech

During the COVID-19 pandemic, people became well aware that viruses can be extremely harmful. But can viruses also be helpful? Bryan Hsu aims to find out by studying viruses that infect bacteria in the bellies of mammals. 

Newswise: UM School of Medicine Researchers Present Interim Results on Meningococcal Vaccine for Infants and Young Children in Africa
Released: 2-Oct-2023 5:05 PM EDT
UM School of Medicine Researchers Present Interim Results on Meningococcal Vaccine for Infants and Young Children in Africa
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) researchers, as part of the Infectious Diseases Clinical Research Consortium (IDCRC), provided an interim analysis showing that the pentavalent (NmCV-5) meningitis vaccine is safe for use in 9-month-old infants in the meningitis belt of sub-Saharan Africa.

Released: 2-Oct-2023 4:05 PM EDT
Trivalent vaccine candidate fights measles, mumps, SARS-CoV-2
Ohio State University

Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.

Newswise: Initiative to Strengthen Response to Infectious Disease Outbreaks in the Mountain West
Released: 2-Oct-2023 12:05 PM EDT
Initiative to Strengthen Response to Infectious Disease Outbreaks in the Mountain West
University of Utah Health

The COVID-19 pandemic spotlighted how a rapid and effective response to infectious disease outbreaks is critical for saving lives and protecting communities. With a $17.5 million, five-year grant from the U.S. Centers for Disease Control and Prevention (CDC), University of Utah researchers, in collaboration with Washington State University, are leading efforts to provide data and tools that guide decisions to improve responses to emerging public health threats in the Mountain West.

Newswise: To prepare for next pandemic, Pitt researchers tackle bird flu
Released: 2-Oct-2023 8:05 AM EDT
To prepare for next pandemic, Pitt researchers tackle bird flu
University of Pittsburgh

Researchers from the University of Pittsburgh and the National Institutes of Health (NIH) Vaccine Research Center have developed an improved way to test potential vaccines against bird flu. The report was published this week in the journal iScience.

Released: 2-Oct-2023 8:05 AM EDT
Study finds SARS-CoV-2-associated sepsis was more common, deadly than previously thought
Brigham and Women’s Hospital

Using data from Mass General Brigham’s electronic health records, Brigham researchers quantified the burden of SARS-CoV-2-associated sepsis early in the pandemic

Released: 29-Sep-2023 8:05 AM EDT
A lethal parasite’s secret weapon: infecting non-immune cells
Ohio State University

The organisms that cause visceral leishmaniasis, a potentially deadly version of the parasitic disease that most often affects the skin, appear to have a secret weapon, new research suggests: They can infect non-immune cells and persist in those uncommon environments.

Released: 28-Sep-2023 10:45 AM EDT
Association for Molecular Pathology Announces 2023 Award Recipients
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award.

Released: 28-Sep-2023 9:05 AM EDT
Research Finds Paxlovid and Legevrio Reduced COVID-19 Hospitalization and Death
Cleveland Clinic

New Cleveland Clinic-led research shows commonly used COVID-19 anti-viral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduce risk of hospitalization and death in high-risk patients with mild disease, even with Omicron subvariants.

Released: 28-Sep-2023 6:05 AM EDT
Researchers find potential way to tweak immune system to help it fight tuberculosis
Boston University

Tuberculosis is old—ancient even. The infectious bacterial disease that plagued Old Testament Israelites and took down pharaohs was eventually stunted by vaccinations, antibiotics, and public health measures like isolation, but it hasn’t been cured yet. More than a million people around the world still die from TB every year.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Newswise: Wistar President and CEO Dario Altieri, M.D., honored by Justinian Society of Philadelphia for Civic Engagement and Leadership
Released: 26-Sep-2023 1:05 PM EDT
Wistar President and CEO Dario Altieri, M.D., honored by Justinian Society of Philadelphia for Civic Engagement and Leadership
Wistar Institute

Dario C. Altieri, M.D., Wistar president and CEO, will be honored by the Justinian Foundation and Society of Philadelphia for exemplifying the finest qualities of scholarship, civic leadership and integrity.

Newswise: Mount Sinai Announces New System Chief of Genomic Medicine
Released: 26-Sep-2023 1:05 PM EDT
Mount Sinai Announces New System Chief of Genomic Medicine
Mount Sinai Health System

Michael F. Murray, MD, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, has been named the new System Chief of the Division of Genomic Medicine and the Clinical Director of the Institute for Genomic Health at Mount Sinai.

Released: 26-Sep-2023 12:05 PM EDT
Association for Molecular Pathology Publishes Report on Use of Multiplex Panels for Diagnosing Infectious Diseases
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has published a review of the current benefits and challenges to using multiplex PCR panels for the detection of microbial pathogens from gastrointestinal, central nervous system, lower respiratory tract, and joint specimens.

Released: 25-Sep-2023 12:05 PM EDT
Contagious omicron strain replicates early in infection
Cornell University

New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly replicate early during infection.

Released: 25-Sep-2023 11:00 AM EDT
New Method Can Improve Assessing Genetic Risks For Non-White Populations
Johns Hopkins Bloomberg School of Public Health

A team led by researchers at Johns Hopkins Bloomberg School of Public Health and the National Cancer Institute has developed a new algorithm for genetic risk-scoring for major diseases across diverse ancestry populations that holds promise for reducing health care disparities.

Newswise: People with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition
21-Sep-2023 8:05 AM EDT
People with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition
Mount Sinai Health System

Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it



close
4.14134